General Information of the Cell Line
Map of Molecular Bioactivity Related to the Cell Line
|
Map of Molecular Bioactivity Related to the Cell Line Cell Line Protein Compound Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Cell Line
Protein ID: PT00877, I-kappa-B kinase 2
| Compound ID | Compound Name | Compound Formula | |
| CP0684739 |
3,4-dichloro-2-ethoxy-N-(2,2,6,6-tetramethylpiperidin-4-yl)benzenesulfonamide
Show/Hide
|
C17H26Cl2N2O3S
|
1 |
| 1 |
IC50 = 56100 nM
|
TI
LI
LO
TS
|
|
|---|---|---|---|
Cell Viability or Cytotoxicity Assay
Protein family and CMB statistics Related to the Cell Line
Cell Lines Derived from the same Tissue Source (Bone marrow)
| Cell Line Name | Organism | Disease | ||
| NB4 | Homo sapiens (Human) | Acute promyelocytic leukemia with PML-RARA | ||
| UT-7/Epo | Homo sapiens (Human) | Adult acute megakaryoblastic leukemia | ||
| UT-7 | Homo sapiens (Human) | Adult acute megakaryoblastic leukemia | ||
| KG-1 | Homo sapiens (Human) | Adult acute myeloid leukemia | ||
| KG-1a | Homo sapiens (Human) | Adult acute myeloid leukemia | ||
| RS4;11 | Homo sapiens (Human) | Adult B acute lymphoblastic leukemia | ||
| Rh30 | Homo sapiens (Human) | Alveolar rhabdomyosarcoma | ||
| MEG-01 | Homo sapiens (Human) | Blast phase chronic myelogenous leukemia, BCR-ABL1 positive | ||
| 697 | Homo sapiens (Human) | Childhood B acute lymphoblastic leukemia | ||
| SUP-B15 | Homo sapiens (Human) | Childhood B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1 | ||
| HAP1 | Homo sapiens (Human) | Chronic myelogenous leukemia, BCR-ABL1 positive | ||
| OCI-Ly1 | Homo sapiens (Human) | Diffuse large B-cell lymphoma | ||
| OCI-Ly3 | Homo sapiens (Human) | Diffuse large B-cell lymphoma activated B-cell type | ||
| TMD8 | Homo sapiens (Human) | Diffuse large B-cell lymphoma activated B-cell type | ||
| OCI-Ly19 | Homo sapiens (Human) | Diffuse large B-cell lymphoma germinal center B-cell type | ||
| TF-1 | Homo sapiens (Human) | Erythroleukemia | ||
| L-540 | Homo sapiens (Human) | Hodgkin lymphoma | ||
| NCI-H345 | Homo sapiens (Human) | Lung small cell carcinoma | ||
| NCI-H526 | Homo sapiens (Human) | Lung small cell carcinoma | ||
| Z-138 | Homo sapiens (Human) | Mantle cell lymphoma | ||
| CAL-1 [Human melanoma] | Homo sapiens (Human) | Melanoma | ||
| SH-SY5Y | Homo sapiens (Human) | Neuroblastoma | ||
| SH-EP1 | Homo sapiens (Human) | Neuroblastoma | ||
| SK-N-BE(2) | Homo sapiens (Human) | Neuroblastoma | ||
| SK-N-SH | Homo sapiens (Human) | Neuroblastoma | ||
| SK-N-BE(2)-C | Homo sapiens (Human) | Neuroblastoma | ||
| SK-N-BE(1) | Homo sapiens (Human) | Neuroblastoma | ||
| GI-CA-N | Homo sapiens (Human) | Neuroblastoma | ||
| LSCC-HD11 | Gallus gallus (Chicken) | - | ||
| IM-9 | Homo sapiens (Human) | - | ||
| LAD 2 | Homo sapiens (Human) | - | ||
| UE6E7T-2 | Homo sapiens (Human) | - | ||
| RBC | Homo sapiens (Human) | - | ||
| Ba/F3 | Mus musculus (Mouse) | - | ||
| FDC-P1 | Mus musculus (Mouse) | - | ||
| S21 | Mus musculus (Mouse) | - | ||
| ANA-1 [Mouse macrophage] | Mus musculus (Mouse) | - | ||
| Y16 | Mus musculus (Mouse) | - | ||
| 32D | Mus musculus (Mouse) | - | ||
| Ba/F3 FLT3-ITD | Mus musculus (Mouse) | - | ||
| Ba/F3 c-Kit D816V | Mus musculus (Mouse) | - | ||
| Bone marrow macrophage immortalized C57BL/6 | Mus musculus (Mouse) | - | ||
| BaF3-BCL | Mus musculus (Mouse) | - | ||
| Ba/F3 NPM-ALK | Mus musculus (Mouse) | - | ||
| Bone marrow macrophage immortalized BALB/c | Mus musculus (Mouse) | - |